{"disease":{"id":"estimate-with-the-contribution-of-optimized-mri-the-prevalence-of-neurological-and-neurovascular-manifestations-on-imaging-in-the-event-of-sars-cov-2.md","name":"estimate with the contribution of optimized mri the prevalence of neurological and neurovascular manifestations on imaging in the event of sars cov 2.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}